Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Pacira Biosciences (PCRX) has a market cap of $1.15 billion USD. According to our data, Pacira Biosciences is ranked No.4801 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.15 B |
32.35%
|
| Dec 31, 2024 | $0.87 B |
-44.16%
|
| Dec 29, 2023 | $1.56 B |
-12.61%
|
| Dec 30, 2022 | $1.78 B |
-35.83%
|
| Dec 31, 2021 | $2.78 B |
0.55%
|
| Dec 31, 2020 | $2.76 B |
32.10%
|
| Dec 31, 2019 | $2.09 B |
5.30%
|
| Dec 31, 2018 | $1.99 B |
-5.76%
|
| Dec 29, 2017 | $2.11 B |
41.33%
|
| Dec 30, 2016 | $1.49 B |
-57.94%
|
| Dec 31, 2015 | $3.55 B |
-13.39%
|
| Dec 31, 2014 | $4.09 B |
54.22%
|
| Dec 31, 2013 | $2.65 B |
229.08%
|
| Dec 31, 2012 | $0.81 B |
101.97%
|
| Dec 30, 2011 | $0.40 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
| Market Cap | = | PCRX Stock Price | * | PCRX Shares Outstanding |
| = | $24.88 | * | 46.28 M | |
| = | $1.15 B |